)
Visual21 Nov 2025
Data center suppliers
Stevanato Group (STVN) investor relations material
Stevanato Group Jefferies London Healthcare Conference 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Jefferies London Healthcare Conference 2025 summary19 Nov, 2025
Company overview and strategy
Over 70 years in the industry, with the last 25 years focused on becoming a global leader in mission-critical products for pharmaceuticals, especially injection-related solutions.
Provides an integrated platform for biopharmaceutical customers, offering vials, syringes, cartridges, and advanced devices like auto-injectors and wearable devices.
Built a global footprint and invested several billion dollars over 25 years to mirror pharma clients' global supply chains and ensure a robust, safe supply chain.
Raised $1.1 billion in a 2021 IPO, reinvesting proceeds to boost R&D and expand capacity in Europe and the US, aiming for $0.5 billion in revenue from new US facilities by 2028.
Focused on being a comprehensive partner for pharma companies, handling all aspects of injection supply chain globally.
Product and market trends
Market leader in cartridges and vials, second in syringes, and leading in glass forming, with a strong presence in high-value products.
High-value product revenue has grown faster than expected, with ongoing capacity expansions in Italy and the US to meet robust demand, especially for biologics.
GLP-1 drugs are a major growth driver, but the company maintains a balanced portfolio across originators and biosimilars to avoid overdependence.
Biosimilar launches, especially in GLP-1, are expected to increase revenue, as biosimilars often replicate originator packaging, facilitating rapid validation.
Analytical services support clients from early drug development, with several hundred molecules filed jointly with clients.
Financial performance and outlook
Revenue doubled in the last five years, with high-value product revenue and EBITDA more than doubling in the last year.
2025 vial segment revenue expected to be up 12% over 2024, with normalization and 1-2% growth in bulk vials and low double-digit growth in easy fill vials by 2026.
Shift in investment and capacity toward high-value products, with strategic focus on biologics and advanced delivery systems.
Engineering segment underwent operational upgrades, rebalancing sites in Italy and Denmark, and expanding capacity to support future growth.
Temporary headwinds in engineering order conversion, but operational performance and pipeline remain healthy.
GLP-1 oral pill market share impact on demand?
Vial market recovery: bulk vs easy fill growth?
Engineering segment order conversion slowdown?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Stevanato Group earnings date
Q4 20255 Mar, 2026
Next Stevanato Group earnings date
Q4 20255 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Stevanato Group S.p.A. is a global provider of containment, delivery, and diagnostic solutions for the pharmaceutical, biotechnology, and life sciences industries. The company specializes in the production of glass containers, such as vials, syringes, and cartridges, used for drug storage and delivery. In addition to its core manufacturing services, Stevanato offers integrated solutions that include drug delivery systems, assembly equipment, and analytical testing. Its products support a range of applications, including injectable drugs, biologics, and diagnostics, helping ensure the safe and effective administration of treatments. The company is headquartered in Piombino Dese, Italy, and its shares are listed on the NYSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage